Cuyue Tang

4.0k total citations
66 papers, 2.2k citations indexed

About

Cuyue Tang is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Cuyue Tang has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 22 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Cuyue Tang's work include Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (19 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers). Cuyue Tang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (19 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers). Cuyue Tang collaborates with scholars based in United States, China and Japan. Cuyue Tang's co-authors include Thomayant Prueksaritanont, Jiunn H. Lin, Magang Shou, Yue Qiu, Thomas H. Rushmore, Mei Qin, Raju Subramanian, Thomas A. Baillie, A. David Rodrigues and Bennett Ma and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Research.

In The Last Decade

Cuyue Tang

66 papers receiving 2.1k citations

Peers

Cuyue Tang
Kamlesh P. Vyas United States
A. David Rodrigues United States
Regina W. Wang United States
Richard Weaver United Kingdom
Pei Hu China
Kamlesh P. Vyas United States
Cuyue Tang
Citations per year, relative to Cuyue Tang Cuyue Tang (= 1×) peers Kamlesh P. Vyas

Countries citing papers authored by Cuyue Tang

Since Specialization
Citations

This map shows the geographic impact of Cuyue Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuyue Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuyue Tang more than expected).

Fields of papers citing papers by Cuyue Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuyue Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuyue Tang. The network helps show where Cuyue Tang may publish in the future.

Co-authorship network of co-authors of Cuyue Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Cuyue Tang. A scholar is included among the top collaborators of Cuyue Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuyue Tang. Cuyue Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blain, Jean‐François, Matthew G. Bursavich, Lori Hrdlicka, et al.. (2016). Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease. Alzheimer s Research & Therapy. 8(1). 34–34. 16 indexed citations
2.
Jin, Hong, Ting Chen, Dooyoung Lee, et al.. (2016). Intracellular Retention of Three Quinuclidine Derivatives in Caco-2 Permeation Experiments: Mechanisms and Impact on Estimating Permeability and Active Efflux Ratio. Drug Metabolism Letters. 10(3). 161–171. 2 indexed citations
3.
Stoiljković, Milan, Liza Leventhal, Angela Chen, et al.. (2015). Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays. Biochemical Pharmacology. 97(4). 576–589. 24 indexed citations
4.
Tang, Cuyue & Devin Welty. (2013). A dynamic view to the modulation of phosphorylation and O-GlcNAcylation by inhibition of O-GlcNAcase. Computational Biology and Chemistry. 45. 9–16. 1 indexed citations
5.
Prueksaritanont, Thomayant & Cuyue Tang. (2012). ADME of Biologics—What Have We Learned from Small Molecules?. The AAPS Journal. 14(3). 410–419. 49 indexed citations
6.
Brnardic, Edward J., Mark E. Fraley, R. M. Garbaccio, et al.. (2010). 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts. Bioorganic & Medicinal Chemistry Letters. 20(10). 3129–3133. 30 indexed citations
7.
Uebele, Victor N., Anthony L. Gotter, Cindy E. Nuss, et al.. (2009). Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice. Journal of Clinical Investigation. 119(6). 1659–1667. 61 indexed citations
9.
Su, Dai‐Shi, Bang-Lin Wan, Kathy Murphy, et al.. (2008). 2-Aminobenzophenones as a Novel Class of Bradykinin B1Receptor Antagonists. Journal of Medicinal Chemistry. 51(13). 3946–3952. 13 indexed citations
10.
Feng, Dong-Mei, Robert M. DiPardo, Jenny Wai, et al.. (2007). A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity. Bioorganic & Medicinal Chemistry Letters. 18(2). 682–687. 15 indexed citations
11.
Su, Dai‐Shi, Bang-Lin Wan, Kathy Murphy, et al.. (2007). Potent bradykinin B1 receptor antagonists: 4-Substituted phenyl cyclohexanes. Bioorganic & Medicinal Chemistry Letters. 17(11). 3006–3009. 5 indexed citations
12.
Kuduk, Scott D., Christina N. Di Marco, Ronald K. Chang, et al.. (2006). 5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(10). 2791–2795. 10 indexed citations
13.
Prueksaritanont, Thomayant, et al.. (2006). Rifampin Induces the in Vitro Oxidative Metabolism, but Not the in Vivo Clearance of Diclofenac in Rhesus Monkeys. Drug Metabolism and Disposition. 34(11). 1806–1810. 4 indexed citations
14.
Kuduk, Scott D., Ronald K. Chang, Christina Ng, et al.. (2005). Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series. Bioorganic & Medicinal Chemistry Letters. 15(17). 3925–3929. 14 indexed citations
15.
Tang, Cuyue, Jerome Hochman, Bennett Ma, Raju Subramanian, & Kamlesh P. Vyas. (2003). Acyl Glucuronidation and Glucosidation of a New and Selective Endothelin ETA Receptor Antagonist in Human Liver Microsomes. Drug Metabolism and Disposition. 31(1). 37–45. 35 indexed citations
16.
Prueksaritanont, Thomayant, Jamie J. Zhao, Bennett Ma, et al.. (2002). Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins. Journal of Pharmacology and Experimental Therapeutics. 301(3). 1042–1051. 219 indexed citations
17.
Prueksaritanont, Thomayant, et al.. (2002). Effects of Fibrates on Metabolism of Statins in Human Hepatocytes. Drug Metabolism and Disposition. 30(11). 1280–1287. 249 indexed citations
18.
Qin, Mei, Cuyue Tang, Yuh J. Lin, Thomas H. Rushmore, & Magang Shou. (2002). Inhibition Kinetics of Monoclonal Antibodies against Cytochromes P450. Drug Metabolism and Disposition. 30(6). 701–708. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026